Hai cercato la traduzione di determinants;determinants da Inglese a Turco

Inglese

Traduttore

determinants;determinants

Traduttore

Turco

Traduttore
Traduttore

Traduci istantaneamente testi, documenti e voce con Lara

Traduci ora

Contributi umani

Da traduttori professionisti, imprese, pagine web e archivi di traduzione disponibili gratuitamente al pubblico.

Aggiungi una traduzione

Inglese

Turco

Informazioni

Inglese

you know, i was wondering about freudian determinants.

Turco

biliyorsunuz, freudyen etkenlere meraklıyımdır.

Ultimo aggiornamento 2015-10-13
Frequenza di utilizzo: 1
Qualità:

Inglese

biological factors are not sufficient determinants of whether a person considers themselves a man or is considered a man.

Turco

biological factors are not sufficient determinants of whether a person considers themselves a man or is considered a man.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Inglese

it is one of the most important determinants of the amount of carbon in the atmosphere, and thus of global temperatures.

Turco

karbon devri çok uzun bir süreyi kapsadığı için, bu devirde deniz düzeyindeki değişikliklerin tarihi oldukça karmaşıktır.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Inglese

this meets the birds' high energy requirements, which are the most important determinants of their flower choice.

Turco

bu da, kuşların, çiçek seçiminde en belirleyici faktörlerden biri olan yüksek enerji gereksinimlerini karşılar.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Inglese

(1997) "determinants of economic growth: a cross-country empirical study.

Turco

"determinants of economic growth: a cross-country empirical study.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Attenzione: contiene formattazione HTML nascosta

Inglese

they also called for information on environmental determinants with positive health impacts such as biodiverse environments, non-motorised means of transport and housing conditions.

Turco

aynı zamanda biyolojik çevre, motorsuz ulaşım yolları ve barınma koşulları gibi olumlu sağlık etkilerine sahip çevresel belirleyiciler hakkında da bilgiler vermişlerdir.

Ultimo aggiornamento 2014-02-06
Frequenza di utilizzo: 1
Qualità:

Inglese

availability of drugs and drug markets are both major determinants and major consequences of drug use, particularly in terms of where and how they interact with the demand for drugs and with responses to the problem at local level.

Turco

uyuşturucuların bulunurluğu ve uyuşturucu pazarları, bilhassa uyuşturucu talebiyle ve soruna yönelik yerel düzeydeki tepkilerle nerede ve nasıl etkileştikleri anlamında, uyuşturucu kullanımının hem başlıca etkenleri hem de başlıca sonuçlarıdır.

Ultimo aggiornamento 2014-02-06
Frequenza di utilizzo: 1
Qualità:

Inglese

some researchers think this may indicate that childhood family experiences are important determinants to homosexuality, or that parents behave this way in response to gender-variant traits in a child.

Turco

bazı araştırmacılar bunun çocuklukta yaşanan ailesel deneyimlerin eşcinsellik için önemli bir belirleyici olduğunu ya da ailenin cinsiyet uyumsuzluğu gösteren çocuğa davranış şeklinin farklılığını gösterdiğini düşünmüştür.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Inglese

:: chapter xvi sections 6–10 give a more elementary account of the exterior algebra, including duality, determinants and minors, and alternating forms.

Turco

:: chapter xvi sections 6–10 give a more elementary account of the exterior algebra, including duality, determinants and minors, and alternating forms.

Ultimo aggiornamento 2016-03-03
Frequenza di utilizzo: 1
Qualità:

Inglese

heading: low dose aspırın assocıated wıth a lower rısk of hepatocellular carcınoma sub heading: results of a study conducted among adults with chronic viral hepatitis İn sweden article text:   worldwide, more than 500,000 cases of incident hepatocellular carcinoma are diagnosed each year, related primarily to chronic infection with hepatitis b or hepatitis c virus. although the incidences of hepatocellular carcinoma and liver-related death are reduced with hepatitis b viral suppression or hepatitis c eradication, they nonetheless persist in high-risk patients, including those with advanced fibrosis. thus, an urgent need remains to develop effective strategies to prevent hepatocellular carcinoma and reduce mortality from cirrhosis. three prior observational studies of this issue lacked detailed data regarding key determinants of hepatic outcomes, including underlying viral hepatitis, cirrhosis, and use of antiviral medication. moreover, information about aspirin-related bleeding events from an unselected population of patients with established chronic viral hepatitis would be valuable. the use of low-dose aspirin the study team examined the use of low-dose aspirin (≤160 mg) in relation to incident hepatocellular carcinoma, liver-related mortality, and gastrointestinal bleeding among adults in sweden with confirmed chronic hepatitis b or hepatitis c infection. the investigators identified 50,275 adults who were diagnosed with chronic hepatitis b or hepatitis c from 2005 through 2015 and who did not have a history of aspirin use. in total 14,205 patients who were starting to take low-dose aspirin were identified by their first filled prescriptions for 90 or more consecutive doses of aspirin. with a median of 7.9 years of follow-up, the estimated cumulative incidence of hepatocellular carcinoma was 4.0% among aspirin users and 8.3% among non-users of aspirin (difference, −4.3 percentage points; 95% confidence interval [ci], −5.0 to −3.6; adjusted hazard ratio [hr], 0.69; 95% ci, 0.62 to 0.76). this inverse association appeared to be duration-dependent; as compared with short-term use (3 months to <1 year), the adjusted hrs were 0.90 (95% ci, 0.76 to 1.06) for 1 to less than 3 years of use, 0.66 (95% ci, 0.56 to 0.78) for 3 to less than 5 years of use, and 0.57 (95% ci, 0.42 to 0.70) for 5 or more years of use. ten-year liver-related mortality was 11.0% among aspirin users and 17.9% among nonusers (difference, −6.9 percentage points [95% ci, −8.1 to −5.7]; adjusted hr 0.73 [95% ci, 0.67 to 0.81]). however, the 10-year risk of gastrointestinal bleeding did not differ significantly between users and non-users of aspirin (7.8% and 6.9%, respectively; difference, 0.9 percentage points; 95% ci, −0.6 to 2.4). the authors concluded that in this registry study among adults with chronic viral hepatitis in sweden, use of low-dose aspirin was associated with a significantly lower risk of hepatocellular carcinoma and lower liver-related mortality than no use of aspirin, without a significantly higher risk of gastrointestinal bleeding. the findings were consistent regardless of sex, cause of hepatitis, or underlying compensated cirrhosis, which suggests that the benefits of aspirin may apply to a broad at-risk population. the results support the need for randomised clinical trials. referans: simon tg, duberg a-s, aleman s, et al. association of aspirin with hepatocellular carcinoma and liver-related mortality. n engl j med 2020; 382:1018-1028 doi: 10.1056/nejmoa1912035

Turco

başlık: düşük dozlu aspırın, hepatoselüler karsinoma alt riskiyle asosiye edildi alt başlık: İsveç'te kronik viral hepatitli yetişkinler arasında yapılan bir Çalışmanın sonuçları, makale: dünya çapında her yıl 500.000'den fazla hepatosellüler karsinom vakası teşhis edilmektedir. hepatit b veya hepatit c virüsü ile kronik enfeksiyon. hepatelüler karsinom ve karaciğerle ilişkili ölüm insidansı, hepatit b viral supresyonu veya

Ultimo aggiornamento 2020-04-11
Frequenza di utilizzo: 1
Qualità:

Riferimento: Anonimo
Attenzione: contiene formattazione HTML nascosta

Alcuni contributi umani con scarsa rilevanza sono stati nascosti.
Mostra i risultati con scarsa rilevanza.

Ottieni una traduzione migliore grazie a
8,768,416,693 contributi umani

Ci sono utenti che chiedono aiuto:



I cookie ci aiutano a fornire i nostri servizi. Utilizzando tali servizi, accetti l'utilizzo dei cookie da parte nostra. Maggiori informazioni. OK